Context Therapeutics Inc. (CNTX): Shareholders' Equity
$60.47M
As of 2025-12-31
$38.17M
As of 2026-06-30
+20.3%
3-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $60.47M | -36.5% | 2026-03-23, Balance as of period end |
| 2024-12-31 | $95.27M | +702.5% | 2026-03-23, Balance as of period end |
| 2023-12-31 | $11.87M | -65.8% | 2025-03-20, Balance as of period end |
| 2022-12-31 | $34.76M | -28.0% | 2024-03-21, Balance as of period end |
| 2021-12-31 | $48.27M | n/m | 2023-03-22, Balance as of period end |
| 2020-12-31 | -$16.92M | n/a | 2022-03-23, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | 2025-12-31 | $60.47M | -36.5% |
| Spero Therapeutics, Inc. (SPRO) | 2025-12-31 | $59.02M | +28.0% |
| Werewolf Therapeutics, Inc. (HOWL) | 2025-12-31 | $24.80M | -66.2% |
| Grace Therapeutics, Inc. (GRCE) | 2026-03-31 | $63.90M | -4.1% |
| Corvus Pharmaceuticals, Inc. (CRVS) | 2025-12-31 | $61.20M | +87.9% |
| Aldeyra Therapeutics, Inc. (ALDX) | 2025-12-31 | $44.25M | -37.7% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $24.10M | -64.8% |
| Rallybio Corp (RLYB) | 2025-12-31 | $57.96M | -6.0% |
| OnKure Therapeutics, Inc. (OKUR) | 2025-12-31 | $56.18M | -45.9% |
Compare CNTX, SPRO, HOWL, GRCE side by side · Screen every company in Pharmaceutical Preparations ↗